PDE10A and cancer: introduces a novel autoantibody, PDE10A IgG, as a biomarker for a rare paraneoplastic neurological syndrome that affects older adults with cancer (particularly lung, renal, and pancreatic carcinomas) and is characterized by hyperkinetic movement disorders (218).